These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 29283429)

  • 1. The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion.
    Mojic M; Takeda K; Hayakawa Y
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
    Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
    Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.
    Dejima H; Hu X; Chen R; Zhang J; Fujimoto J; Parra ER; Haymaker C; Hubert SM; Duose D; Solis LM; Su D; Fukuoka J; Tabata K; Pham HHN; Mcgranahan N; Zhang B; Ye J; Ying L; Little L; Gumbs C; Chow CW; Estecio MR; Godoy MCB; Antonoff MB; Sepesi B; Pass HI; Behrens C; Zhang J; Vaporciyan AA; Heymach JV; Scheet P; Lee JJ; Wu J; Futreal PA; Reuben A; Kadara H; Wistuba II; Zhang J
    Nat Commun; 2021 May; 12(1):2722. PubMed ID: 33976164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escape from IFN-γ-dependent immunosurveillance in tumorigenesis.
    Lin CF; Lin CM; Lee KY; Wu SY; Feng PH; Chen KY; Chuang HC; Chen CL; Wang YC; Tseng PC; Tsai TT
    J Biomed Sci; 2017 Feb; 24(1):10. PubMed ID: 28143527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.
    Takeda K; Nakayama M; Hayakawa Y; Kojima Y; Ikeda H; Imai N; Ogasawara K; Okumura K; Thomas DM; Smyth MJ
    Nat Commun; 2017 Feb; 8():14607. PubMed ID: 28233863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning cancer fate: the unremitting role of host immunity.
    Calì B; Molon B; Viola A
    Open Biol; 2017 Apr; 7(4):. PubMed ID: 28404796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.
    Eichmüller SB; Osen W; Mandelboim O; Seliger B
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28383653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of regulatory T cells to cancer: A review.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):7983-7993. PubMed ID: 30317612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors.
    Gorbachev AV; Kobayashi H; Kudo D; Tannenbaum CS; Finke JH; Shu S; Farber JM; Fairchild RL
    J Immunol; 2007 Feb; 178(4):2278-86. PubMed ID: 17277133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.
    Di Carlo E; Comes A; Orengo AM; Rosso O; Meazza R; Musiani P; Colombo MP; Ferrini S
    J Immunol; 2004 Feb; 172(3):1540-7. PubMed ID: 14734732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Regulatory T Cells Undermined or Endorsed by Different Type-1 Cytokines.
    Piconese S; Barnaba V
    Adv Exp Med Biol; 2015; 850():17-30. PubMed ID: 26324343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
    Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
    Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased accumulation of immune regulatory cells is correlated to the antitumor effect of IFN-γ overexpression in the tumor.
    Carrio R; Torroella-Kouri M; Libreros S; García-Areas RA; Iragavarapu-Charyulu V; López DM
    Int J Oncol; 2011 Dec; 39(6):1619-27. PubMed ID: 21874231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
    Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
    Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):191-201. PubMed ID: 7905286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-1, IFN gamma and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma.
    Van Ginderachter JA; Liu Y; Geldhof AB; Brijs L; Thielemans K; De Baetselier P; Raes G
    Int J Cancer; 2000 Aug; 87(4):539-47. PubMed ID: 10918195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
    Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
    Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of cellular immune response by Ipomoea obscura and Ipobscurine alkaloid attenuates tumor growth in mice.
    Hamsa TP; Kuttan G
    Can J Physiol Pharmacol; 2011 Apr; 89(4):259-68. PubMed ID: 21539469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.